United States
Germany
Japan
United Kingdom
China
RPA2 mouse monoclonal antibody, clone OTI9A1 (formerly 9A1)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Antibodies
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Carrier-free (BSA/glycerol-free) RPA2 mouse monoclonal antibody, clone OTI9A1 (formerly 9A1)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
CNY 1,999.00
CNY 2,700.00
现货
Anti-SERPINA1 mouse monoclonal antibody, clone OTI9A1 (formerly 9A1)
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Dog, Monkey |
CNY 3,999.00
2周
RPA2 mouse monoclonal antibody, clone OTI1H10 (formerly 1H10)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Carrier-free (BSA/glycerol-free) RPA2 mouse monoclonal antibody, clone OTI1H10 (formerly 1H10)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
RPA2 mouse monoclonal antibody, clone OTI9A1 (formerly 9A1)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Anti-USP13 mouse monoclonal antibody, clone OTI4G11 (formerly 4G11)
| Applications | IHC, IP, WB |
| Reactivities | Human, Monkey, Dog, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI6E5 (formerly 6E5)
| Applications | IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 1,999.00
CNY 2,700.00
现货
Anti-SERPINA1 mouse monoclonal antibody, clone OTI11G2 (formerly 11G2)
| Applications | IHC, IP, WB |
| Reactivities | Human, Dog, Monkey |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI4C2 (formerly 4C2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Target Symbol
Knockout (KO) Validation
Assay Types
Brands
Pathways
- Progesterone-mediated oocyte maturation (24)
- Colorectal cancer (23)
- Neurotrophin signaling pathway (23)
- Pathways in cancer (23)
- Acute myeloid leukemia (21)
- Bladder cancer (21)
- Chemokine signaling pathway (21)
- Chronic myeloid leukemia (21)
- Endometrial cancer (21)
- ErbB signaling pathway (21)
- Focal adhesion (21)
- Glioma (21)
- Insulin signaling pathway (21)
- Long-term depression (21)
- Long-term potentiation (21)
- MAPK signaling pathway (21)
- Melanoma (21)
- Natural killer cell mediated cytotoxicity (21)
- Non-small cell lung cancer (21)
- Pancreatic cancer (21)
- Prostate cancer (21)
- Regulation of actin cytoskeleton (21)
- Renal cell carcinoma (21)
- Thyroid cancer (21)
- Vascular smooth muscle contraction (21)
- mTOR signaling pathway (21)
- Oocyte meiosis (15)
- Prion diseases (14)
- T cell receptor signaling pathway (13)
- Toll-like receptor signaling pathway (13)
- Adherens junction (12)
- Alzheimer's disease (12)
- Axon guidance (12)
- B cell receptor signaling pathway (12)
- Complement and coagulation cascades (12)
- Dorso-ventral axis formation (12)
- Fc epsilon RI signaling pathway (12)
- Fc gamma R-mediated phagocytosis (12)
- Gap junction (12)
- GnRH signaling pathway (12)
- Melanogenesis (12)
- NOD-like receptor signaling pathway (12)
- TGF-beta signaling pathway (12)
- Type II diabetes mellitus (12)
- VEGF signaling pathway (12)
- Cell cycle (6)
- DNA replication (6)
- Homologous recombination (6)
- Mismatch repair (6)
- Nucleotide excision repair (6)
- p53 signaling pathway (5)
- Non-homologous end-joining (4)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Huntington's disease (2)
- Hematopoietic cell lineage (1)
- Primary immunodeficiency (1)
